US CDMO Recro Pharma has paid roughly $50 million in a cash-and-stock deal to buy Irisys, a compatriot CDMO with operations on both the East and West Coasts. Recro said...
Extending its engagement with innovative Chinese start-ups, Evonik Venture Capital is placing fresh bets on two funds. The subsidiary of the German chemical producer said...
US biotech Moderna announced on Aug. 26 that it had completed its filing with the US Food and Drug Administration (FDA) for full marketing approval of its mRNA-based...
Private equity company SK Capital Partners has purchased a majority stake in the monomers, polymers and European businesses of Deltech Holdings. Financial terms and the...
Swiss specialty chemicals producer Clariant has agreed to acquire the remaining 70% of Brazilian Personal Care Specialties company Beraca after taking a 30% stake in 2015...
First to receive US approval under an Emergency Use Authorization (EUA) in late 2020, the BioNTech/Pfizer Covid-19 vaccine on Aug. 23 became the first to be fully...
Swiss specialty chemicals company Sika has agreed to sell its European industrial coatings business to US paints and coatings group Sherwin-Williams for an undisclosed...
Swiss CDMO Lonza plans to invest an undisclosed sum to establish drug product manufacturing capabilities at its site in Guangzhou, China. The investment in the central...
Fu Xiangsheng, Vice Chairman of the China Petroleum and Chemical Industry Federation, characterized China`s chemical industry as having a a surplus of basic chemicals and...
The increasing complexity of drug products brings pharmaceutical companies significant manufacturing challenges arising from the pandemic. This includes disrupting supply...
